(Q33677550)

28 July 2017

1 reference

title

Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease (English)

1 reference

28 July 2017

1 reference

Somerville AL

1

1 reference

28 July 2017

Wright DH

series ordinal

2

1 reference

28 July 2017

Rotschafer JC

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

19

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

702-707

1 reference

An updated comparison of drug dosing methods. Part IV: Vancomycin

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Vancomycin administration and monitoring reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization imm

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Falsely elevated serum vancomycin concentrations in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

STRUCTURE STUDIES ON VANCOMYCIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.9.702.31548

10.1592/PHCO.19.9.702.31548

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference